I-Corps: Injectable, Highly Sticky, Antimicrobial, and Hemostatic Adhesive for Cornea Injury Repair
I-Corps: Injectable, Highly Sticky, Antimicrobial, and Hemostatic Adhesive for Cornea Injury Repair
批准号:
1848656
负责人:
Iman Noshadi
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2019-02-28
中文摘要
这个i-Corps项目的更广泛的影响/商业潜力是针对眼睛创伤的治疗,特别是角膜损伤。眼外伤的治疗需要先进的手术设备和专业的手术中心。眼角膜移植市场目前在美国以每年40000的速度增长,预计从2017年到2023年将以10.8%的速度增长。该项目的目标是伤口护理市场(2016年)182.2亿美元,预计将达到262.4亿美元(2023年)。社会影响包括能够迅速向战斗中的士兵等病人、创伤病人以及老年和儿科病人提供护理,并减少手术和手术后的费用。这项技术可以扩展到修复肺、肝、心脏或肾脏等组织,将其覆盖范围扩大到更多的人群,并使其获得医疗好处。这个新的化学平台旨在实现组织粘连,但化学成分可以稍作改变,以制造用于更广泛的生物医学应用的材料。对这种新型材料平台的研究,就像了解结构-性质关系一样,提供了许多教学和推广机会,涉及从化学、材料科学、化学、机械和电气工程到生物学的各个学科的学生。这个i-Corps项目开发了一种改进的水凝胶,用于制造外科应用的抗菌、止血和高度粘合的胶水。这是一个材料平台,可以制造成本效益高、无缝合和用户友好的粘合剂,以愈合对生物组织的损伤,并节省手术和手术后的时间和成本。眼外伤手术目前的主要需求是减少手术和术后的时间和成本。目前,还没有食品和药物管理局批准的这种材料平台来取代目前使用的有效缝合技术。该材料有望具有生物兼容性、生物降解性、无毒性和良好的组织粘附性,即使在体液存在的情况下也是如此。该平台还可以帮助凝血、促进愈合和抑制细菌生长。这一创新可能会绕过目前手术和术后方法在角膜修复方面的局限性,未来可能会扩展到其他人体组织的修复。这一奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
The broader impact/commercial potential of this I-Corps project targets treatment of ocular trauma, in particular corneal injuries. Ocular trauma treatment requires advanced surgical equipment and specialty surgical centers. The Corneal Transplant Market, currently at 40000 per year in the US is expected to grow at 10.8% from 2017 to 2023. The project targets the wound care market of $18.22 billion (2016), expected to reach $26.24 billion (2023). The societal impact entails enabling rapid care provision to patients like soldiers in combat, to trauma and elderly and pediatric patients, as well as reduction of operative and post-operative costs. The technology can be extended to repairing tissues such as lung, liver, heart or kidneys, expanding its reach and medical benefits to larger populations. This novel chemistry platform aims toward tissue adhesion, but the chemistry could be slightly altered to make materials for a broader range of biomedical applications. Study of such novel material platforms, like understanding of structure-property relationships, offers numerous teaching and outreach opportunities involving students from subject disciplines spanning chemistry, material sciences, chemical, mechanical, and electrical engineering to biology. This I-Corps project has developed a modified hydrogel to make antimicrobial, hemostatic and highly adhesive glue for surgical applications. This is a material platform to make cost-effective, sutureless, and user-friendly adhesives to heal injury to biological tissue and save operative and post-operative time and cost. The current primary needs for ocular trauma surgery entail operative and postoperative time and cost reduction. Currently, there are no such Food and Drug Administration-approved material platforms to replace the presently used techniques of suturing effectively. The material is expected to enjoy biocompatibility, biodegradability, no toxicity and excellent adhesion to tissues, even in the presence of body fluids. The platform may also aid in blood coagulation, facilitate healing and inhibit bacterial growth. This innovation will potentially circumvent the limitations of current surgical and post-operative approaches in corneal repair, and in the future may be extended to repair of other human tissues.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PFI-TT: Development of Highly Adhesive Hydrogel for Cornea Tissue Regeneration
-
批准号:2137727
-
项目类别:Standard Grant
-
资助金额:$25.0万
-
财政年份:2021
-
负责人:Iman Noshadi
-
依托单位:
I-Corps: Self-oxygen generating biomaterial and a biocompatible electrochemical device to generate oxygen for tissue engineering
-
批准号:2005317
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2020
-
负责人:Iman Noshadi
-
依托单位:
PFI-TT: Development of Highly Adhesive Hydrogel for Cornea Tissue Regeneration
-
批准号:1919092
-
项目类别:Standard Grant
-
资助金额:$25.0万
-
财政年份:2019
-
负责人:Iman Noshadi
-
依托单位:
海外基金